1. (1) Each preceptor shall:

   1. (a) apply for board approval to be a preceptor when the preceptor is a pharmacist. For pharmacists, the board shall issue an endorsement on the pharmacist's license when requirements are met;

   2. (b) have been actively engaged in:

      1. (i) the practice of pharmacy for one year, unless otherwise approved by the board; or
      2. (ii) other approved disciplines;
   3. (c) be actively engaged in the pharmacy profession or other approved discipline or healthcare profession while acting as preceptor;
   4. (d) not have been convicted of violation of any statutes or rules relating to pharmacy within three years prior to application;
   5. (e) be acutely aware of the responsibilities governing professional conduct in this state;
   6. (f) have current knowledge of developments in the profession by exhibiting such attendances, readings, and actions, which conform to the best traditions of pharmacy;
   7. (g) make reports and certifications as required by a school of pharmacy;
   8. (h) not be permitted to leave an intern to work alone or unsupervised to assume the responsibility of a pharmacist; and
   9. (i) complete a training course as approved by the ACPE or the school of pharmacy prior to applying for a pharmacist preceptor endorsement.
2. (2) The repackaging, labeling, counseling, dispensing, or distribution of drugs shall be under the supervision of a supervising pharmacist.
3. (3) A supervising pharmacist or preceptor may precept more than one intern at a time.

Authorizing statute(s): 37-7-201, MCA

Implementing statute(s): 37-7-201, MCA

History: NEW, Eff. 5/20/72; AMD, 1977 MAR p. 106, Eff. 9/23/77; AMD, 1980 MAR p. 126, Eff. 1/18/80; TRANS, from Dept. of Prof. & Occup. Lic., Ch. 274, L. 1981, Eff. 7/1/81; AMD, 1997 MAR p. 2060, Eff. 11/18/97; AMD, 2001 MAR p. 783, Eff. 5/11/01; AMD, 2002 MAR p. 178, Eff. 2/1/02; TRANS, from Commerce, 2002 MAR p. 904; AMD, 2002 MAR p. 3605, Eff. 12/27/02; AMD, 2007 MAR p. 1936, Eff. 11/22/07; AMD, 2011 MAR p. 1148, Eff. 6/24/11; AMD, 2019 MAR p. 1633, Eff. 9/21/19; AMD, 2024 MAR p. 2219, Eff. 9/21/24.